Canada approves Merck grass allergy immunotherapy

February 3, 2014 by The Associated Press

Merck & Co. says it's won its first approval for its new immunotherapy tablet for grass allergies, from regulators in Canada.

The drug, called Grastek, gradually reduced to grass pollen, by desensitizing the immune system to the substance triggering the allergic reaction. Most treatments just temporarily relieve sneezing, itching and other symptoms.

The world's third-biggest drugmaker, based in Whitehouse Station, N.J., has partnered with ALK-Abello to market it in North America. ALK-Abello sells it in Europe as Grazas.

In the U.S., the Food and Drug Administration is weighing approval of both Grastek and an immunotherapy tablet for ragweed allergies. The tablets dissolve under the tongue and are taken daily for a year or so.

They could become an alternative to months of uncomfortable allergy shots.

Explore further: Merck says FDA reviewing its ragweed allergy therapy

Related Stories

Merck says FDA reviewing its ragweed allergy therapy

May 8, 2013
Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, ...

Merck: FDA reviewing tablet to eliminate allergy

March 27, 2013
Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving ...

FDA panel considers first pill for ragweed allergy

January 28, 2014
(HealthDay)—There may be good news coming in the form of a pill for the millions of Americans who suffer from ragweed allergy.

Allergy shots during pregnancy may decrease allergies in children

November 8, 2013
Expecting mothers who suffer from allergies may want to consider another vaccination in addition to the flu shot and Tdap. A study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma ...

Study demonstrates that once-a-day pill offers relief from ragweed allergy symptoms

May 7, 2013
An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal ...

DNA of peanut-allergic kids changes with immune therapy, study finds

January 31, 2014
Treating a peanut allergy with oral immunotherapy changes the DNA of the patient's immune cells, according to a new study from the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford. The ...

Recommended for you

Does your child really have a food allergy?

July 24, 2017
(HealthDay)—Many people misunderstand what food allergies are, and even doctors can be confused about how to best diagnose them, suggests a new report from the American Academy of Pediatrics.

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.